Literature DB >> 12687664

Natural history of rhizomelic chondrodysplasia punctata.

Amy L White1, Peggy Modaff, Francesca Holland-Morris, Richard M Pauli.   

Abstract

Rhizomelic chondrodysplasia punctata (RCP) is a rare autosomal recessive disorder with many associated medical complications. Prior to this study, natural history information about RCP was limited and based on experiences with small populations of affected individuals. We delineate the natural history of RCP through systematic analysis of 35 previously unreported individuals (as well as review of 62 literature cases with respect to survival and cause of death). Survival, growth, and developmental expectations and medical needs are summarized based upon experience with this population. Survival is greater among this population than previously reported, with 90% surviving up to 1 year and 50% surviving up to 6 years. Cause of death is most often respiratory problem. All infants with RCP have joint contractures, bilateral cataracts, and severe growth and psychomotor delays. Recommendations for health supervision of children with RCP and for parental counseling are presented. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12687664     DOI: 10.1002/ajmg.a.20009

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  30 in total

Review 1.  Natural history and management of cervical spine disease in chondrodysplasia punctata and coumarin embryopathy.

Authors:  Timothy W Vogel; Arnold H Menezes
Journal:  Childs Nerv Syst       Date:  2012-01-25       Impact factor: 1.475

2.  Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination.

Authors:  Tiago Ferreira da Silva; Jessica Eira; André T Lopes; Ana R Malheiro; Vera Sousa; Adrienne Luoma; Robin L Avila; Ronald J A Wanders; Wilhelm W Just; Daniel A Kirschner; Mónica M Sousa; Pedro Brites
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

3.  Precursor of ether phospholipids is synthesized by a flavoenzyme through covalent catalysis.

Authors:  Simone Nenci; Valentina Piano; Sara Rosati; Alessandro Aliverti; Vittorio Pandini; Marco W Fraaije; Albert J R Heck; Dale E Edmondson; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

4.  Blind sterile 2 (bs2), a hypomorphic mutation in Agps, results in cataracts and male sterility in mice.

Authors:  R Liegel; B Chang; R Dubielzig; D J Sidjanin
Journal:  Mol Genet Metab       Date:  2011-02-25       Impact factor: 4.797

Review 5.  Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.

Authors:  Ana R Malheiro; Tiago Ferreira da Silva; Pedro Brites
Journal:  J Inherit Metab Dis       Date:  2014-11-29       Impact factor: 4.982

6.  Colonic perforation in the first few hours of life associated with rhizomelic chondrodysplasia punctata.

Authors:  Timothy Fairbanks; Sherif Emil
Journal:  Pediatr Surg Int       Date:  2005-10-13       Impact factor: 1.827

7.  Specific entities affecting the craniocervical region: syndromes affecting the craniocervical junction.

Authors:  Arnold H Menezes; Timothy W Vogel
Journal:  Childs Nerv Syst       Date:  2008-03-28       Impact factor: 1.475

8.  A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.

Authors:  Nancy Braverman; Rui Zhang; Li Chen; Graeme Nimmo; Sarah Scheper; Tammy Tran; Rupsa Chaudhury; Ann Moser; Steven Steinberg
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

Review 9.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

10.  Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata.

Authors:  Tarik Luisman; Tara Smith; Shawn Ritchie; Karen E Malone
Journal:  Orphanet J Rare Dis       Date:  2021-07-06       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.